VISKA
Live / Applied — Third extension granted (statement of use) (as of 07 Jan 2026)
What this means for you
Not registered yet, but its 31 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97867543
- Mark type
- Stylized text
- Filed
- 31 Mar 2023
- Published for opposition
- 14 May 2024
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic preparations, pharmaceutical preparations, and vaccines that act as activation immunotherapies for the treatment and prevention of diseases and disorders, namely, aging, atherosclerosis, cancer, congestive heart failure, Nonalcoholic Steatohepatitis (NASH) disease, neurodegenerative diseases, namely, Alzheimers and Parkinsons, obesity, pulmonary fibrosis, and viral diseases, namely, SARS-CoV-2, HIV, influenza, SARS
- Class 042 — Scientific and technological services: Research and development of therapeutic preparations, pharmaceuticals, and vaccines
Owner
- Viska Bio, Inc., Cambridge, MA, US
- Viska Bio, Inc., Cambridge, MA, US
Prosecution history
- 08 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jan 2026 — SOU EXTENSION 3 GRANTED
- 07 Jan 2026 — SOU EXTENSION 3 FILED
- 07 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jul 2025 — SOU EXTENSION 2 GRANTED
- 09 Jul 2025 — SOU EXTENSION 2 FILED
- 09 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Jan 2025 — SOU EXTENSION 1 GRANTED
- 09 Jan 2025 — SOU EXTENSION 1 FILED
- 09 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 09 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 14 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 May 2024 — PUBLISHED FOR OPPOSITION